Cannatrek signs medicinal cannabis strategic partnership agreement with Chemist Warehouse

Medicinal cannabis company Cannatrek Limited today announced it has entered into an exclusive agreement with Chemist Warehouse, Australia’s largest pharmacy chain, to supply medicinal cannabis products and services to treat illnesses including pain, inflammation, anxiety and insomnia.

What the Down-Scheduling of CBD from a Schedule 4 to a Schedule 3 Medicine Really Means

Cannatrek to supply medicinal cannabis products to LYPHE Group to support Project TWENTY21

Australian seed-to-patient medicinal cannabis producer Cannatrek today announced it will supply medicinal cannabis products to LYPHE Group in support of Project TWENTY21, Europe’s first and largest national medical cannabis registry.

Cannatrek to export medicinal cannabis to Germany-based Nimbus Health, becoming a key supplier to Europe’s biggest market

Australian seed-to-patient medicinal cannabis producer Cannatrek today announced it has signed a multi-year supply agreement to export dried cannabis flowers to Germany-based Nimbus Health.